Nike Operating Cash Flow decreased by 52.1% to $222.00M in Q2 2025 compared to the prior quarter. Year-over-year, this metric declined by 43.7%, from $394.00M to $222.00M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows a downward trend with a -13.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.01B | $1.11B | $247.00M | $2.68B | $1.15B | $357.00M | $2.39B | $837.00M | $2.25B | -$66.00M | $1.51B | $3.37B | $2.62B | $394.00M | $407.00M | $2.43B | $463.00M | $222.00M |
| QoQ Change | — | -44.8% | -77.8% | +984.6% | -57.0% | -69.0% | +570.6% | -65.0% | +169.2% | -102.9% | >999% | +123.1% | -22.2% | -85.0% | +3.3% | +498.0% | -81.0% | -52.1% |
| YoY Change | — | — | — | — | -42.8% | -67.9% | +869.2% | -68.8% | +95.7% | -118.5% | -37.0% | +302.3% | +16.2% | +697.0% | -73.0% | -27.7% | -82.3% | -43.7% |